scholarly article | Q13442814 |
P50 | author | Dragan Jevremović | Q73966654 |
Amir Lerman | Q77286771 | ||
P2093 | author name string | Robert D Simari | |
Richard G Vile | |||
Tyra A Witt | |||
Rajiv Gulati | |||
Timothy E Peterson | |||
Cheryl S Mueske | |||
Laurel S Kleppe | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 7 | |
P304 | page(s) | 1520-1526 | |
P577 | publication date | 2003-09-02 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Autologous culture-modified mononuclear cells confer vascular protection after arterial injury | |
P478 | volume | 108 |
Q36067191 | 1H-pyrrole-2,5-dione-based small molecule-induced generation of mesenchymal stem cell-derived functional endothelial cells that facilitate rapid endothelialization after vascular injury |
Q39147616 | A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia |
Q28539764 | A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells |
Q91386840 | Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair |
Q41881596 | Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway--a pilot study |
Q48909705 | Autologous endothelial progenitor cells transplantation promoting endothelial recovery in mice |
Q54487029 | Biotin-streptavidin cross-bridging: a novel and feasible approach for targeting transplanted cells to damaged tissue. |
Q35223568 | Blood outgrowth endothelial cells reduce hypoxia-mediated fibroblast to myofibroblast conversion by decreasing proangiogenic cytokines |
Q59136377 | Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties |
Q35070477 | Bone mesenchymal stem cells contributed to the neointimal formation after arterial injury |
Q37172734 | Carotid repair using autologous adipose-derived endothelial cells |
Q37388609 | Cell therapy with bone marrow cells for myocardial regeneration |
Q33395710 | Changes in number and biological function of endothelial progenitor cells in hypertension disorder complicating pregnancy |
Q35675635 | Characterization of Endothelial Progenitor Cell Interactions with Human Tropoelastin |
Q35751792 | Circulating angiogenic cell populations, vascular function, and arterial stiffness |
Q36721957 | Clinical Application of Endothelial Progenitor Cell: Are We Ready? |
Q37405963 | Defining the potential for cell therapy for vascular disease using animal models |
Q33494576 | Effects of Xuezhikang and pravastatin on circulating endothelial progenitor cells in patients with essential hypertension |
Q43686538 | Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury |
Q37234958 | Endothelial cell transfusion ameliorates endothelial dysfunction in 5/6 nephrectomized rats. |
Q38072175 | Endothelial progenitor cell-based therapy for pulmonary arterial hypertension |
Q37563882 | Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders |
Q33572269 | Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress |
Q89038320 | Endothelial progenitor cells in age-related vascular remodeling |
Q37377904 | Endothelial progenitor cells restore renal function in chronic experimental renovascular disease |
Q28303395 | Endothelial progenitor cells: identity defined? |
Q37325660 | Endothelial progenitor cells: implications for cardiovascular disease |
Q37362743 | Endothelial progenitor cells: markers of vascular reparative capacity |
Q37176444 | Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. |
Q84862145 | Establishment of outgrowth endothelial cells from peripheral blood |
Q35847119 | Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults |
Q36681485 | Genetic modification of cerebral arterial wall: implications for prevention and treatment of cerebral vasospasm |
Q36392994 | High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents |
Q41849182 | Human Umbilical Cord Blood–Derived Endothelial Cells Reendothelialize Vein Grafts and Prevent Thrombosis |
Q46688029 | Human umbilical cord blood-derived f-macrophages retain pluripotentiality after thrombopoietin expansion |
Q37178485 | Increased circulating inflammatory endothelial cells in blacks with essential hypertension |
Q36484420 | Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms |
Q26769864 | Olive Oil and the Hallmarks of Aging |
Q36407227 | Peripheral blood as a source of stem cells for regenerative medicine. |
Q36630308 | Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells |
Q37368684 | Potential use of endothelial progenitor cells for regeneration of the vasculature |
Q36839005 | Promise of endothelial progenitor cell for treatment of diabetic retinopathy |
Q24651247 | Recent insights into the mechanisms of vasospastic angina |
Q36446920 | Stem cells for the ischaemic heart |
Q38165146 | Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases |
Q33862257 | Targeting microspheres and cells to polyethylene glycol-modified biological surfaces |
Q37276042 | The promise of cell-based therapies for diabetic complications: challenges and solutions |
Q43767394 | The relationship between neutrophil lymphocyte ratio and non-dipper hypertension |
Q36275663 | The role of circulating precursors in vascular repair and lesion formation. |
Q37734546 | The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development |
Q36130517 | Transplantation of EPCs overexpressing PDGFR-β promotes vascular repair in the early phase after vascular injury |
Q33945229 | Transplantation of endothelial progenitor cells in treating rats with IgA nephropathy |
Q38116924 | Understanding vascular development |
Q64064564 | VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues |
Q37697685 | VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells |
Q37340859 | Vascular effects of a low-carbohydrate high-protein diet. |
Q38326653 | Vascular injury and repair: a potential target for cell therapies |
Q41917815 | Vasoprotective effects of human CD34+ cells: towards clinical applications |
Search more.